Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain.

Liu B, Liu X, Tang SJ.

Front Microbiol. 2016 Feb 10;7:103. doi: 10.3389/fmicb.2016.00103. eCollection 2016. Review.

2.

Protopanaxatriol Ginsenoside Rh1 Upregulates Phase II Antioxidant Enzyme Gene Expression in Rat Primary Astrocytes: Involvement of MAP Kinases and Nrf2/ARE Signaling.

Jung JS, Lee SY, Kim DH, Kim HS.

Biomol Ther (Seoul). 2016 Jan;24(1):33-9. doi: 10.4062/biomolther.2015.129. Epub 2016 Jan 1.

3.

Microglial cell dysregulation in brain aging and neurodegeneration.

von Bernhardi R, Eugenín-von Bernhardi L, Eugenín J.

Front Aging Neurosci. 2015 Jul 20;7:124. doi: 10.3389/fnagi.2015.00124. eCollection 2015. Review.

4.

Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase.

Wang Q, Chu CH, Qian L, Chen SH, Wilson B, Oyarzabal E, Jiang L, Ali S, Robinson B, Kim HC, Hong JS.

J Neurosci. 2014 Sep 10;34(37):12490-503. doi: 10.1523/JNEUROSCI.2238-14.2014.

5.

Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases.

Wang Q, Chu CH, Oyarzabal E, Jiang L, Chen SH, Wilson B, Qian L, Hong JS.

Glia. 2014 Dec;62(12):2034-43. doi: 10.1002/glia.22724. Epub 2014 Jul 17.

6.

Pesticides, microglial NOX2, and Parkinson's disease.

Taetzsch T, Block ML.

J Biochem Mol Toxicol. 2013 Feb;27(2):137-49. doi: 10.1002/jbt.21464. Epub 2013 Jan 24.

7.
8.

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice.

Wang Q, Shin EJ, Nguyen XK, Li Q, Bach JH, Bing G, Kim WK, Kim HC, Hong JS.

J Neuroinflammation. 2012 Jun 13;9:124. doi: 10.1186/1742-2094-9-124.

9.

Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.

Surace MJ, Block ML.

Cell Mol Life Sci. 2012 Jul;69(14):2409-27. doi: 10.1007/s00018-012-1015-4. Epub 2012 May 13. Review.

10.

Negative regulation of glial engulfment activity by Draper terminates glial responses to axon injury.

Logan MA, Hackett R, Doherty J, Sheehan A, Speese SD, Freeman MR.

Nat Neurosci. 2012 Mar 18;15(5):722-30. doi: 10.1038/nn.3066.

11.

Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91phox subunit of NADPH oxidase.

Wang Q, Zhou H, Gao H, Chen SH, Chu CH, Wilson B, Hong JS.

J Neuroinflammation. 2012 Feb 16;9:32. doi: 10.1186/1742-2094-9-32.

12.

Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Hutchinson MR, Shavit Y, Grace PM, Rice KC, Maier SF, Watkins LR.

Pharmacol Rev. 2011 Sep;63(3):772-810. doi: 10.1124/pr.110.004135. Epub 2011 Jul 13. Review.

13.

Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord.

Chechneva OV, Mayrhofer F, Daugherty DJ, Pleasure DE, Hong JS, Deng W.

Neurobiol Dis. 2011 Oct;44(1):63-72. doi: 10.1016/j.nbd.2011.06.004. Epub 2011 Jun 24.

14.

Addiction, adolescence, and innate immune gene induction.

Crews FT, Vetreno RP.

Front Psychiatry. 2011 Apr 27;2:19. doi: 10.3389/fpsyt.2011.00019. eCollection 2011.

15.

Induction of innate immune genes in brain create the neurobiology of addiction.

Crews FT, Zou J, Qin L.

Brain Behav Immun. 2011 Jun;25 Suppl 1:S4-S12. doi: 10.1016/j.bbi.2011.03.003. Epub 2011 Mar 21. Review.

16.

The endotoxin-induced neuroinflammation model of Parkinson's disease.

Tufekci KU, Genc S, Genc K.

Parkinsons Dis. 2011 Jan 18;2011:487450. doi: 10.4061/2011/487450.

17.

Neuropsychopharmacological understanding for therapeutic application of morphinans.

Shin EJ, Hong JS, Kim HC.

Arch Pharm Res. 2010 Oct;33(10):1575-87. doi: 10.1007/s12272-010-1009-4. Epub 2010 Oct 30. Review.

18.

Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.

Simonyi A, He Y, Sheng W, Sun AY, Wood WG, Weisman GA, Sun GY.

Mol Neurobiol. 2010 Jun;41(2-3):73-86. doi: 10.1007/s12035-010-8107-7. Epub 2010 Mar 2. Review.

19.

Centrally administered lipopolysaccharide elicits sympathetic excitation via NAD(P)H oxidase-dependent mitogen-activated protein kinase signaling.

Zhang ZH, Yu Y, Wei SG, Felder RB.

J Hypertens. 2010 Apr;28(4):806-16. doi: 10.1097/HJH.0b013e3283358b6e.

20.

Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia.

Zhang P, Lokuta KM, Turner DE, Liu B.

J Neurochem. 2010 Jan;112(2):434-43. doi: 10.1111/j.1471-4159.2009.06477.x. Epub 2009 Nov 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk